Allan L. Goldstein Ph.D.
Net Worth
Last updated:
What is Allan L. Goldstein Ph.D. net worth?
The estimated net worth of Dr. Allan L. Goldstein Ph.D. is at least $1,801,500 as of 30 Jun 2021. He owns shares worth $1,500 as insider and has received compensation worth at least $1,800,000 in RegeneRx Biopharmaceuticals, Inc..
What is the salary of Allan L. Goldstein Ph.D.?
Dr. Allan L. Goldstein Ph.D. salary is $90,000 per year as Founder, Chairman, Chief Scientific Officer & Chairman of Scientific Advisor Board in RegeneRx Biopharmaceuticals, Inc..
How old is Allan L. Goldstein Ph.D.?
Dr. Allan L. Goldstein Ph.D. is 87 years old, born in 1938.
What stocks does Allan L. Goldstein Ph.D. currently own?
As insider, Dr. Allan L. Goldstein Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| RegeneRx Biopharmaceuticals, Inc. (RGRX) | Founder, Chairman, Chief Scientific Officer & Chairman of Scientific Advisor Board | 93,750 | $0.02 | $1,500 |
What does RegeneRx Biopharmaceuticals, Inc. do?
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue. It has strategic partnerships with Lee's Pharmaceutical Group and GtreeBNT Co., Ltd. The company was formerly known as Alpha 1 Biomedicals, Inc. and changed its name to RegeneRx Biopharmaceuticals, Inc. in 2000. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland.
Allan L. Goldstein Ph.D. insider trading
RegeneRx Biopharmaceuticals, Inc.
Dr. Allan L. Goldstein Ph.D. has made only one insider trade between 2005-2021, according to the Form 4 filled with the SEC. He purchased 93,750 units of RGRX stock worth $33,750 on 30 Jun 2021.
As of 30 Jun 2021 he still owns at least 93,750 units of RGRX stock.
RegeneRx Biopharmaceuticals key executives
RegeneRx Biopharmaceuticals, Inc. executives and other stock owners filed with the SEC:
- Dr. Allan L. Goldstein Ph.D. (87) Founder, Chairman, Chief Scientific Officer & Chairman of Scientific Advisor Board
- Mr. J. J. Finkelstein (73) Pres, Chief Executive Officer & Director